Related Experiment Videos
CD69 expression on primitive progenitor cells and hematopoietic malignancies
P Tassone1, M C Turco, F Tuccillo
1Department of Experimental and Clinical Medicine, Facoltà di Medicina e Chirurgia, Catanzaro, Italy.
Tissue Antigens
|July 1, 1996
Summary
CD69 is expressed on early hematopoietic progenitor cells and immature myeloid leukemia cells. Its expression levels correlate with cell immaturity, suggesting a role in early hematopoiesis and leukemic transformation.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- CD69 is an early activation antigen on lymphocytes and is present on various bone marrow cells.
- Understanding CD69's role in hematopoiesis and malignancies is crucial.
Purpose of the Study:
- To characterize CD69 distribution in hematopoietic progenitor cells and malignancies.
- To investigate the biological role of CD69 in normal and malignant hematopoiesis.
Main Methods:
- Utilized a novel high-affinity anti-CD69 monoclonal antibody (mAb UN6).
- Analyzed CD69 expression on mobilized peripheral blood CD34+ cells and various myeloid/lymphoid malignancies.
- Examined CD69 expression during cytokine-induced differentiation.
Main Results:
- Detected CD69 on mobilized peripheral blood CD34+ cells, with expression density correlating with the CD34bright Thy-1bright immature phenotype.
- Observed moderate down-regulation of CD69 during cytokine-induced differentiation.
- Found that CD69 expression in hematopoietic malignancies correlates with an immature myeloid phenotype.
Conclusions:
- CD69 plays a role in the early stages of hematopoiesis.
- CD69 expression patterns may be linked to leukemic transformation.